ACUTE LEUKEMIAS XVIII
Biology and Treatment Strategies

Munich, Germany - March 19-22, 2023

International Symposium

S U N D A Y , March 19, 2023

16.30-17.30
SATELLITE SYMPOSIUM (SAT I)

Industry sponsored Satellite
(AbbVie Deutschland GmbH)
Lecture Hall III (Overflow Rooms: LHs IV+V)

Transforming the AML Treatment Paradigm: An Expert Conversation

16.30-16.35
Welcome and Introduction
H. Döhner, Ulm, DE

16.35-16.45
Changing Foundations in AML Treatment
G. Roboz, New York, NY, USA

16:45-16:55
Building on New Treatment Approaches
Ch. Craddock, Birmingham, UK

16:55-17.25
Panel Discussion and Q&A
All Faculty

17:25-17.30
Closing Remarks
H. Döhner, Ulm, DE

 

M O N D A Y , March 20, 2023

12:45-13:45
SATELLITE SYMPOSIUM (SAT II)

Industry sponsored Satellite
(Pfizer GmbH)
Lecture Hall III (Overflow Rooms: LHs IV/V)

Targeted treatment in ALL and AML

12:45-12:50
Welcome and Introduction

12:50-13:10
M. Subklewe, Munich, DE

13:10-13:30
R. Wäsch, Freiburg, DE

13:30-13:45 Q & A

 

18:00-19:00
SATELLITE SYMPOSIUM (SAT III)

Industry sponsored Satellite
(Bristol Myers Squibb)
Lecture Hall III (Overflow Rooms: LHs IV/V)

Maintenance in AML: How far Have we Come and Where are we Headed?

18:00-18:10
Welcome and Introduction

Gail JH. Roboz (Chair)
Weill Cornell Medical College
New York, NY, USA

18:10-18:30
How do I Maintain Remission in Patients with AML?

Klaus H. Metzeler
University Hospital Leipzig
Germany

18:30-18:50
Thomas Cluzeau

University Hospital of Nice
France

18.50-19:00
Q & A and Closing Remarks

Gail J. Roboz, Klaus H. Metzeler, and Thomas Cluzeau

 

T U E S D A Y, March 21, 2023

16:00-17:00 SATELLITE SYMPOSIUM (SAT IV)
Industry sponsored Satellite
(Jazz Pharmaceuticals)
Lecture Hall III (Overflow Rooms LHs IV+V)

Evidence-Based Practice for High-Risk AML:
Classifications, Clinical Studies, and the Real World

16:00-16.02
Welcome and Introduction
L. Bullinger, Berlin, DE

16:02-16:17
High-Risk AML in 2023 – Have our New Classifications Improved our Management of Patients?

L. Bullinger, Berlin, DE

16:17-17:32
From Clinical Trials to the Clinic: Why Real-World Evidence Matters.

A. Venditti, Rome, I

17:32-17:48
Case Study Debate: Integrating Knowledge from Clinical Studies

and Real-World Evidence
Th. Schroeder, Essen, DE

17:48-17:58 Audience: Q&A

17:58-18:00 Close
L. Bullinger, Berlin, DE